Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Placenta. 2014 Mar 6;35(5):303–304. doi: 10.1016/j.placenta.2014.02.012

The Human Placenta Project: Placental Structure, Development, and Function in Real Time

Alan E Guttmacher 1, Yvonne T Maddox 1, Catherine Y Spong 1
PMCID: PMC3999347  NIHMSID: NIHMS573583  PMID: 24661567

Abstract

Despite its crucial role in the health of both the fetus and the pregnant woman, the placenta is the least understood human organ. Since a growing body of evidence also underscores the importance of placental development in the lifelong health of both mother and offspring, this lack of knowledge about placental structure and function is particularly concerning. Given modern approaches and technologies and the ability to develop new methods, we propose a coordinated “Human Placenta Project,” with the ultimate goal of understanding human placental structure, development, and function in real time.


The placenta is the least understood human organ and arguably one of the more important, not only for the health of a woman and her fetus during pregnancy but also for the lifelong health of both. Throughout fetal development, the placenta functions both as a unique agent of human symbiosis and as the fetal renal, respiratory, hepatic, gastrointestinal, endocrine, and immune systems. Yet, our understanding of the human placenta is woefully limited.

Placental structure and function affect the health of the mother, as seen in the development of insulin resistance1 and of preeclampsia, gestational hypertension, and eclampsia2,3,4,5. Placental dysfunction affects the fetus, causing prematurity6 and fetal growth and neurodevelopmental abnormalities7. The concept of “placental origins of adult disease” stem from studies where variations in placental development affect the supply of nutrients to the fetus and the developmrnt of systems linked to adult diseases8,9. In addition, placental size and shape have been linked to maternal nutrition and the lifespan of men10,11.Pregnancy is a “stress test” for lifelong maternal health; placental function may be both a marker and cause of future cardiovascular disease12,13,14,15.The maternal-fetal-placental unit's unique ability for tolerance and immunologic acceptance,16,17,18,19 coupled with the aggressive invasive growth of the placenta into the decidua, parallels that of cancer cells.

Current significant knowledge gaps in placental biology and medicine reflect inadequate molecular and cellular definitions of placental phenotypes and lack of delineation of the mechanisms by which such phenotypes are associated with feto-placental disorders, maternal health complications, neonatal diseases, and adult-onset diseases. This paucity of information is primarily due to limitations in current non-invasive “interrogation” of the placenta. Existing techniques essentially rely on post-delivery examination of the placenta, and typically focus only on molecular and histological investigation. This is akin to relying on postmortem histology alone to understand how the human body functions, and malfunctions, throughout life. That the placenta is the human organ for which animal models have proven least adequate further constrains research.20,21

Lack of knowledge is the problem. A problem for which we believe a concerted effort, The Human Placenta Project, would make substantial inroads.

It is time to harness modern approaches and technologies – and to develop new ones – to understand human placental structure, development, and function in real time, which would be an ultimate goal of the Human Placenta Project. An early step will be to gather experts who study the placenta – and other creative thinkers who have never previously applied their approaches to the placenta – along with potential funders, to help define the scientific opportunities and approaches, long-term goals, intermediate metrics and deliverables, and timetable of the Project. The Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health is currently organizing such a meeting for 2014 and looks forward to partnering with others to support the science that emerges.

Understanding the human placenta would lead to both preventive and therapeutic interventions with lifelong impact. For example, creating new understanding of placental function and novel techniques for monitoring function in vivo could lower rates of preeclampsia and, may lower mothers' lifelong risks for cardiovascular disease. New understanding and monitoring of placental function could also help identify pregnancies at increased risk for preterm delivery and even lead to decreased rates of prematurity, an important public health need. Placenta-based approaches to prevention of low birthweight could reduce rates of stroke, hypertension, and myocardial infarction when the infants become adults. Recent data indicate that the placenta may play a role in at least promulgating transgenerational effects, which suggests that using better knowledge of the placenta and placenta-based interventions to improve the course of pregnancy might someday even improve the health of multiple generations.22,23

A growing body of data indicates that placental structural and functional abnormalities can cause numerous adverse pregnancy outcomes. Recent evidence also underscores the importance of placental development in long term health and disease for both mother and offspring. Yet, limited understanding of in vivo human placental development hinders our ability to identify abnormal placental structure or function, predict their impact on maternal and fetal health, or improve clinical decision making. By increasing understanding of the placenta and the ability to prevent and treat placental abnormalities, we could improve not only pregnancy outcome but the lifelong health of the child and the mother. The Human Placenta Project should have an historic impact on research and on the health of all who ever have been or will be attached to a human placenta.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

REFERENCES

  • 1.Lacroix M, Kina E, Hivert MF. Maternal/fetal determinants of insulin resistance in women during pregnancy and in offspring over life. Curr Diab Rep. 2013;13(2):238–44. doi: 10.1007/s11892-012-0360-x. [DOI] [PubMed] [Google Scholar]
  • 2.McMaster MT, Zhou Y, Fisher SJ. Abnormal placentation and the syndrome of preeclampsia. Semin Nephrol. 2004;24(6):540–7. doi: 10.1016/s0270-9295(04)00124-x. [DOI] [PubMed] [Google Scholar]
  • 3.Fisher SJ. The placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia. Reprod Biol Endocrinol. 2004;2:53. doi: 10.1186/1477-7827-2-53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Zhou Y, Gormley MJ, Hunkapiller NM, Kapidzic M, Stolyarov Y, Feng V, Nishida M, Drake PM, Bianco K, Wang F, McMaster MT, Fisher SJ. Reversal of gene dysregulation in cultured cytotrophoblasts reveals possible causes of preeclampsia. J Clin Invest. 2013;123(7):2862–72. doi: 10.1172/JCI66966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Silasi M, Cohen B, Karumanchi SA, Rana S. Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia. Obstet Gynecol Clin North Am. 2010;37(2):239–53. doi: 10.1016/j.ogc.2010.02.013. [DOI] [PubMed] [Google Scholar]
  • 6.Norwitz ER. Defective implantation and placentation: laying the blueprint for pregnancy complications. Reprod Biomed Online. 2006;13(4):591–9. doi: 10.1016/s1472-6483(10)60649-9. [DOI] [PubMed] [Google Scholar]
  • 7.Rees S, Inder T. Fetal and neonatal origins of altered brain development. Early Hum Dev. 2005;81(9):753–61. doi: 10.1016/j.earlhumdev.2005.07.004. [DOI] [PubMed] [Google Scholar]
  • 8.Barker DJ, Larsen G, Osmond C, Thornburg KL, Kajantie E, Eriksson JG. Int J Epidemiol. 2012 Oct;41(5):1394–9. doi: 10.1093/ije/dys116. doi: 10.1093/ije/dys116. Epub 2012 Sep 19. [DOI] [PubMed] [Google Scholar]
  • 9.Barker DJ, Thornburg KL. Placental programming of chronic diseases, cancer and lifespan: a review Placenta. 2013 Oct;34(10):841–5. doi: 10.1016/j.placenta.2013.07.063. doi: 10.1016/j.placenta.2013.07.063. Epub 2013 Aug 2..) [DOI] [PubMed] [Google Scholar]
  • 10.Barker DJ, Osmond C, Thornburg KL, Kajantie E, Eriksson JG. Placenta. 2011 Oct;32(10):783–7. doi: 10.1016/j.placenta.2011.07.031. doi: 10.1016/j.placenta.2011.07.031. Epub 2011 Aug 9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Winder NR, Krishnaveni GV, Veena SR, Hill JC, Karat CL, Thornburg KL, Fall CH, Barker DJ. Placenta. 2011 Nov;32(11):806–10. doi: 10.1016/j.placenta.2011.09.001. doi: 10.1016/j.placenta.2011.09.001. Epub 2011 Sep 14.) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Hennington BS, Alexander BT. Linking IUGR and Blood Pressure: Insight into the Human Origins of Cardiovascular Disease. Circulation. 2013 Oct 17; doi: 10.1161/CIRCULATIONAHA.113.006323. Epub ahead of print. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Rich-Edwards JW, Fraser A, Lawlor DA, Catov JM. Pregnancy Characteristics and Women's Future Cardiovascular Health: An Underused Opportunity to Improve Women's Health? Epidemiol Rev. 2013 Sep 11; doi: 10.1093/epirev/mxt006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Ehrenthal DB, Catov JM. Importance of engaging obstetrician/gynecologists in cardiovascular disease prevention. Curr Opin Cardiol. 2013;28(5):547–53. doi: 10.1097/HCO.0b013e328364298e. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Saade GR. Pregnancy as a window to future health. Obstet Gynecol. 2009;114(5):958–60. doi: 10.1097/AOG.0b013e3181bf5588. [DOI] [PubMed] [Google Scholar]
  • 16.Cross JC, Werb Z, Fisher SJ. Implantation and the placenta: key pieces of the development puzzle. Science. 1994;266(5190):1508–18. doi: 10.1126/science.7985020. [DOI] [PubMed] [Google Scholar]
  • 17.Krishnan L, Nguyen T, McComb S. From mice to women: the conundrum of immunity to infection during pregnancy. J Reprod Immunol. 2013;97(1):62–73. doi: 10.1016/j.jri.2012.10.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Svensson-Arvelund J, Ernerudh J, Buse E, Cline JM, Haeger JD, Dixon D, Markert UR, Pfarrer C, Vos PD, Faas MM. The Placenta in Toxicology. Part II: Systemic and Local Immune Adaptations in Pregnancy. Toxicol Pathol. 2013 Mar 26; doi: 10.1177/0192623313482205. [DOI] [PubMed] [Google Scholar]
  • 19.Arck PC, Hecher K. Fetomaternal immune cross-talk and its consequences for maternal and offspring's health. Nat Med. 2013;19(5):548–56. doi: 10.1038/nm.3160. [DOI] [PubMed] [Google Scholar]
  • 20.Carter AM. Animal models of human placentation--a review. Placenta. 2007;28(Suppl A):S41–7. doi: 10.1016/j.placenta.2006.11.002. [DOI] [PubMed] [Google Scholar]
  • 21.James JL, Carter AM, Chamley LW. Human placentation from nidation to 5 weeks of gestation. Part II: Tools to model the crucial first days. J. Placenta. 2012;33(5):335–42. doi: 10.1016/j.placenta.2012.01.019. [DOI] [PubMed] [Google Scholar]
  • 22.Padmanabhan N, Jia D, Geary-Joo C, Wu X, Ferguson-Smith AC, Fung E, Bieda MC, Snyder FF, Gravel RA, Cross JC, Watson ED. Mutation in folate metabolism causes epigenetic instability and transgenerational effects on development. Cell. 2013;155(1):81–93. doi: 10.1016/j.cell.2013.09.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Roseboom TJ, Watson ED. The next generation of disease risk: Are the effects of prenatal nutrition transmitted across generations? Evidence from animal and human studies. Placenta. 2012 doi: 10.1016/j.placenta.2012.07.018. [DOI] [PubMed] [Google Scholar]

RESOURCES